S&P/ASX 200 Index (ASX: XJO) shares are in the red today, dragged lower largely due to concerns over iron ore exports.
Meanwhile, on The Bull this week, Dylan Evans from Catapult Wealth explains his views on three ASX 200 shares.
Let's check them out.
Image source: Getty Images
Transurban Group (ASX: TCL)
The Transurban share price is $14.93, down 0.8% today and down 1% over six months.
Evans has a buy rating on this ASX 200 industrials share, and explains:
TCL operates toll roads in Australia and the United States. It generates reliable inflation linked cash flows, underpinning a relatively defensive stock.
The shares are sensitive to rising interest rates, partially due to its significant debt, which, in our view, has weighed on the stock in the past few years.
During the same time, Transurban has been growing traffic volumes and has been involved in completing several significant projects, including the West Gate Tunnel in Melbourne.
Any easing in inflation and interest rates would boost the company's performance.
In the meantime, Transurban offers an attractive dividend yield, reliable earnings and a development pipeline with long term growth potential.
Sonic Healthcare Ltd (ASX: SHL)
The Sonic Healthcare share price is $18.96, up 0.9% on Thursday and down 18% over six months.
Evans has a hold rating on this ASX 200 healthcare share, and says:
Sonic is a leading global provider of clinical laboratory services, including pathology and radiology. The company increased revenue by 17 per cent in the first half of 2026 when compared to the prior corresponding period. Net profit after tax was up 10 per cent.
The company is on track to achieve full year EBITDA guidance of between $1.87 billion to $1.95 billion on a constant currency basis.
If positive momentum continues, Sonic looks like a solid value play. Sonic was recently trading on a modest price/earnings multiple of about 17 times and a partially franked dividend yield of about 5.7 per cent.
An ageing population underpins demand for laboratory services, so SHL should be able to grow at high double digits over the long term.
A2 Milk Company Ltd (ASX: A2M)
The A2 Milk share price is $5.29, down 1.1% today and 44% over the past six months.
Evans has a sell rating on this ASX 200 consumer staples share, commenting:
This infant milk formula company recently initiated a voluntary recall of three small batches of contaminated product sold only in the United States.
While the recall didn't impact the key Chinese market, it poses a reputational risk in a country and segment that is sensitive to brand reputation.
A recent trading update revealed supply chain disruptions are constraining product availability despite strong underlying demand.
The shares have remained under pressure since April when the company downgraded guidance in full year 2026.
